Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

Business Leaders

Latest NewsCompaniesMarketsEconomy & ForexCommoditiesInterest RatesBusiness LeadersFinance Pro.CalendarSectors 
HomeAll NewsMost read newsBusiness Leaders Biography
Portrait de Jean-Pierre Sommadossi
Age : 65
Public asset : 56,270,867 USD
Country of residence : Unknown
Linked companies : Atea Pharmaceuticals, Inc. - Kezar Life Sciences, Inc. - ABG Acquisition Corp. I

Biography of Jean-Pierre Sommadossi 
Dr. Jean-Pierre Sommadossi is a Chairman at Kezar Life Sciences, Inc., a Chairman, President & Chief Executive Officer at Atea Pharmaceuticals, Inc., a Member-Discovery Council at Harvard Medical School and an Independent Director at ABG Acquisition Corp. I. He is on the Board of Directors at Rafael Pharmaceuticals, Inc., The BioExec Institute, Inc. and ABG Acquisition Corp. I. Dr. Sommadossi was previously employed as a Chairman, President & Chief Executive Officer by Idenix Pharmaceuticals LLC, a Co-Founder by Pharmasset, Inc., a Professor by The University of Alabama at Birmingham, a Fogarty Fellow by Medical College of Virginia, a Fogarty Fellow by National Cancer Institute, and an Advisor by Puretech Health LLC. He also served on the board at Alzheon, Inc. and Kinex Pharmaceuticals, Inc. He received his doctorate degree from the University of Marseille.


Current positions of Jean-Pierre Sommadossi 
Holdings of Jean-Pierre Sommadossi 
Jean-Pierre Sommadossi : Personal Network 
Most Read News 
01/18ELON MUSK : Tesla investors urge judge to order Musk repay $13 billion for SolarCity deal
RE
01/13JACK DORSEY : Jack Dorsey's Block to build an open bitcoin mining system
RE
01/14ELON MUSK : Musk says Tesla to accept dogecoin for merchandise
RE
01/20ALAN JOPE : Unilever strategy under scrutiny after short-lived GSK skirmish
RE
01/24ELON MUSK : Tesla countersues JPMorgan, claims bank sought 'windfall' after Musk tweet
RE
01/23NELSON PELTZ : Nelson Peltz's Trian builds stake in Unilever - source
RE
01/12MARTIN SORRELL : Sorrell's S4 says trading well ahead of guidance
RE
01/25JOHN HESS : Hess Corp sees higher capital spending, production in 2022
RE
01/13AMANCIO ORTEGA : Inditex founder Amancio Ortega buys Toronto's Royal Bank Plaza for $916 mln
RE
01/17ELON MUSK : Top Energy News of the Day
DJ
More news


© 2022 People and Ownership :   
Jean-Pierre Sommadossi : Connections 


Latest news about Jean-Pierre Sommadossi 
2021Atea Pharmaceuticals to Terminate Roche Collaboration for Development of COVID-19 Oral Antiviral Treatment -- Shares Slump in Pre-Market
MT
2021Roche, Atea Pharmaceuticals Cancel COVID-19 Therapy Development Partnership
MT
2021Atea Pharmaceuticals to Terminate Roche Collaboration for Joint Development of COVID-19 Oral Antiviral Treatment
MT
2021ATEA PHARMACEUTICALS : Shares Plunge After COVID-19 Pill Candidate Misses Phase 2 Primary Endpoint
MT
2021Atea's Covid-19 Trial Misses Objective in Overall Patient Population
DJ
More news